期刊文献+

上消化道疾病患者幽门螺杆菌的感染率及耐药性 被引量:9

Study on infection rate and resistance of Helicobacter pylori from patients with gastroenteric disease
下载PDF
导出
摘要 目的 了解西安地区胃肠疾病患者幽门螺杆菌的感染率及对常用抗菌素的敏感性 ,为幽门螺杆感染治疗的药物选择提供依据 .方法 采用细菌培养的方法对 2 5 9例胃肠疾病患者胃粘膜活检标本进行了幽门螺杆菌的分离鉴定 ,并用琼脂稀释和浓度梯度法对随机抽取的 5 0株幽门螺杆菌进行了抗生素敏感性试验 .结果 西安地区胃肠疾病患者幽门螺杆菌的感染率为 74% ,其中胃癌的感染率为 5 8% ;胃溃疡的感染率为 75 % ;十二指肠溃疡的感染率为 95 % ;其他胃肠疾病也有不同的感染率 ,幽门螺杆菌对阿莫西林和克拉霉素的敏感率均为 10 0 % ,两种检测方法无差异 .幽门螺杆菌对甲硝唑的耐药率较高 ,琼脂稀释法为 38% ,浓度梯度法为 5 8% ,存在一定的差异 .结论 幽门螺杆菌是胃肠疾病发生的重要因素 ,在西安地区阿莫西林和克拉霉素是治疗幽门螺杆菌感染的首选药物 ,控制甲硝唑在治疗幽门螺杆菌感染中的使用 .在进行幽门螺杆菌对甲硝唑的敏感试验时 ,应采取琼脂稀释和浓度梯度两种方法 。 AIM To investigate infection rate and resistance to common drugs of Helicobacter pylori(Hp) of patients with upper diseases in Xi'an area. METHODS Hp in gastric biopsy specimens from 259 patients with gastroenteric diseases was studied by bacterial culture method. In vitro , antimicrobial susceptibility of 50 strains Hp of random selection was tested by E test and agar dilution method. RESULTS Hp infection rate in patients with gastroenteric diseases was 74% inXi'an area. The detection rates of Hp in patients with gastric cancer, gastric ulcer, duodenal ulcer were 58%,76% and95% respectively. Susceptibility rate of Hp to amoxicillinand clarithromycin was 100%. Hp was highly resistant to metronidazole, and its resistance rate was found to be 38% by agar dilution method and 58% by E test method. CONCLUSION Hp directly leads to gastroenteric diseases. Amoxicillin and clarithromycin are first choice drugs for treatment of Hp infection,but metronidazole is not usually used in Xi'an area. In susceptibility testing of Hp to metronidazole, both E test method and agar dilution method are recommended.
出处 《第四军医大学学报》 2000年第10期1250-1252,共3页 Journal of the Fourth Military Medical University
关键词 上消化道疾病 幽门螺杆菌 感染率 耐药性 gastroenteric disease Helicobacter pylori infection rate resistance
  • 相关文献

参考文献3

二级参考文献10

共引文献73

同被引文献31

  • 1王健祥.枸橼酸铋雷尼替丁结晶母液中雷尼替丁的回收利用[J].华西药学杂志,2005,20(4):372-372. 被引量:1
  • 2胡品津,胡伏莲.中华医学会第四次全国幽门螺杆菌学术会议纪要[J].中华消化杂志,2005,25(11):698-699. 被引量:55
  • 3高文,胡伏莲.幽门螺杆菌感染与胃肠道外疾病[J].中国医刊,2007,42(2):22-24. 被引量:30
  • 4史碧山,佘菲菲,林赛榕,潘玉凤,江勇.幽门螺杆菌检测法比较及药敏试验[J].中华消化内镜杂志,1997,14(1):26-28. 被引量:60
  • 5National Committee for Clinical Laboratory Standards. Performance standards for antimierobial susceptibility testing. 14th Inform Suppl. M100-S14. National Committee for Clinical Laboratory, Standards, Wayne, PA, 2004. 被引量:1
  • 6Yahavz J, Shmuely Ho Niv Y, et al. In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure. Diagn Microbiol Infect Dis, 2006, 55:81-83. 被引量:1
  • 7Heep M, Rieger U, Beck D, et al. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobaeter pylori and Mycobaeterium tuberculosis. Antimicrob Agents Chemother, 2000, 44 : 1075-1077. 被引量:1
  • 8Fujimura S, Kato S, Kawamura T, et al. In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults. J Antimicrob Chemother, 2002, 49:541-543. 被引量:1
  • 9Platsouka E, Zissis NP, Portolos J, et al. Bacterial susceptibilities to piperacillin/tazobactam in a tertiary care hospital 5 year rcview[J]. J Chemother,2003,15(1) :27-30. 被引量:1
  • 10Higgins PG,Wisplinghoff H,Stefanik D,et al. In vitro activities of the beta lactamase inhibitors clavulanic acid, sulbaetam, and tazobactam alone or in combination with beta lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains [ J ]. Antimicrob Agents Chemother,2004,48(5) :1586-1592. 被引量:1

引证文献9

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部